Merck: Merck and Jiangsu Hengrui Pharma ink exclusive license agreement for HRS5346, an investigational oral Lipoprotein(a) inhibitor, for cardiovascular disease
Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological
Read full article »
Merck is a New Jersey-based multinational biopharmaceutical company that develops and commercializes novel therapeutics and vaccines for the treatment of a range of diseases.
Read more